1 active not recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Xospata: new trials by email Literature Review of Xospata trials Research Report on Xospata
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML Venetoclax, Decitabine for Injection, Cytarabine - AML, Adult, Chemotherapy Effect | Phase 3 | Active not recruiting | Chen Suning | 188 | 2022-03-01 | 2024-10-03 |
| A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations Allogeneic Hematopoietic Stem Cell Transplantation, Asparaginase Erwinia chrysanthemi, Biospecimen Collection - Acute Myeloid Leukemia | Phase 3 | Recruiting | Children's Oncology Group | 1400 | 2020-07-21 | 2026-09-17 |
Chen Suning (1) · Children's Oncology Group (1)
Australia (1) · Canada (1) · China (1) · Puerto Rico (1) · United States (1)
Todd M Cooper (1)
PMID 33843815, PMID 36892565, PMID 38107263, PMID 38947228, PMID 40009498, PMID 42497367
U10CA180886 (1)